| In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cells SN Nadig, J Więckiewicz, DC Wu, G Warnecke, W Zhang, S Luo, ... Nature medicine 16 (7), 809-813, 2010 | 349 | 2010 |
| Ex vivo–expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model F Issa, J Hester, R Goto, SN Nadig, TE Goodacre, K Wood Transplantation 90 (12), 1321-1327, 2010 | 241 | 2010 |
| Epstein–Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group JL Mellinger, L Rossaro, WE Naugler, SN Nadig, H Appelman, WM Lee, ... Digestive diseases and sciences 59, 1630-1637, 2014 | 105 | 2014 |
| Society of pediatric liver transplantation: current registry status 2011‐2018 SA Elisofon, JC Magee, VL Ng, SP Horslen, V Fioravanti, J Economides, ... Pediatric transplantation 24 (1), e13605, 2020 | 100 | 2020 |
| Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo J Hester, A Schiopu, SN Nadig, KJ Wood American Journal of Transplantation 12 (8), 2008-2016, 2012 | 96 | 2012 |
| Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model DC Wu, J Hester, SN Nadig, W Zhang, P Trzonkowski, D Gray, S Hughes, ... Transplantation 96 (8), 707-716, 2013 | 94 | 2013 |
| Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection G Feng, SN Nadig, L Bäckdahl, S Beck, RS Francis, A Schiopu, ... Science translational medicine 3 (83), 83ra40-83ra40, 2011 | 87 | 2011 |
| Regulatory T cells in transplantation KJ Wood, A Bushell, M Carvalho-Gaspar, G Feng, R Francis, N Jones, ... Regulatory T Cells and Clinical Application, 307-323, 2008 | 87 | 2008 |
| Transplantation tolerance: lessons from experimental rodent models CI Kingsley, SN Nadig, KJ Wood Transplant International 20 (10), 828-841, 2007 | 76 | 2007 |
| A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation HM Gonzales, JW McGillicuddy, V Rohan, JL Chandler, SN Nadig, ... American Journal of Transplantation 20 (8), 1969-1983, 2020 | 64 | 2020 |
| HDAC inhibition helps post-MI healing by modulating macrophage polarization D Kimbrough, SH Wang, LH Wright, SK Mani, H Kasiganesan, AC LaRue, ... Journal of molecular and cellular cardiology 119, 51-63, 2018 | 46 | 2018 |
| Regulation of transplant arteriosclerosis by CD25+ CD4+ T cells generated to alloantigen in vivo G Warnecke, A Bushell, SN Nadig, KJ Wood Transplantation 83 (11), 1459-1465, 2007 | 44 | 2007 |
| Predicting and preventing readmissions in kidney transplant recipients KL Covert, JN Fleming, C Staino, JP Casale, KM Boyle, NA Pilch, ... Clinical transplantation 30 (7), 779-786, 2016 | 40 | 2016 |
| Prediction of medication non‐adherence and associated outcomes in pediatric kidney transplant recipients J Connelly, N Pilch, M Oliver, C Jordan, J Fleming, H Meadows, P Baliga, ... Pediatric Transplantation 19 (5), 555-562, 2015 | 40 | 2015 |
| Impact of the new kidney allocation system on perioperative outcomes and costs in kidney transplantation DJ Taber, D DuBay, JW McGillicuddy, S Nadig, CF Bratton, KD Chavin, ... Journal of the American College of Surgeons 224 (4), 585-592, 2017 | 39 | 2017 |
| Marginal donors in liver transplantation: expanding the donor pool SN Nadig, CF Bratton, SJ Karp Journal of Surgical Education 64 (1), 46-50, 2007 | 34 | 2007 |
| Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity SN Nadig, SK Dixit, N Levey, S Esckilsen, K Miller, W Dennis, C Atkinson, ... RSC advances 5 (54), 43552-43562, 2015 | 31 | 2015 |
| CD4+ regulatory T cells generated in vitro with IFN-γ and allogeneic APC inhibit transplant arteriosclerosis G Warnecke, G Feng, R Goto, SN Nadig, R Francis, KJ Wood, A Bushell The American journal of pathology 177 (1), 464-472, 2010 | 31 | 2010 |
| Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients AH Janneh, MF Kassir, CJ Dwyer, P Chakraborty, JS Pierce, PA Flume, ... Scientific reports 11 (1), 14232, 2021 | 28 | 2021 |
| Evaluation of orthogonal testing algorithm for detection of SARS-CoV-2 IgG antibodies G Xu, AJ Emanuel, S Nadig, S Mehrotra, BA Caddell, SR Curry, FS Nolte, ... Clinical chemistry 66 (12), 1531-1537, 2020 | 28 | 2020 |
